- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2090-9098
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Scope of SARS-CoV-2 variants, mutations, and vaccine technologies ; volume:34 ; number:1 ; day:26 ; month:3 ; year:2022 ; pages:1-13 ; date:12.2022
The Egyptian Journal of Internal Medicine ; 34, Heft 1 (26.3.2022), 1-13, 12.2022
- Creator
-
Wambani, Josephine
Okoth, Patrick
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43162-022-00121-z
- URN
-
urn:nbn:de:101:1-2022061810033486370201
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wambani, Josephine
- Okoth, Patrick
- SpringerLink (Online service)
Other Objects (12)
Considering epitopes conservity in targeting SARS-CoV-2 mutations in variants: a novel immunoinformatics approach to vaccine design
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
Challenges and developments in universal vaccine design against SARS-CoV-2 variants
A potent, broadly protective vaccine against SARS-CoV-2 variants of concern
An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies
Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models
Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants
An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants
Considering epitopes conservity in targeting SARS-CoV-2 mutations in variants: a novel immunoinformatics approach to vaccine design
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
Challenges and developments in universal vaccine design against SARS-CoV-2 variants
A potent, broadly protective vaccine against SARS-CoV-2 variants of concern
An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies
Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models
Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants
An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants
Considering epitopes conservity in targeting SARS-CoV-2 mutations in variants: a novel immunoinformatics approach to vaccine design
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
Challenges and developments in universal vaccine design against SARS-CoV-2 variants
A potent, broadly protective vaccine against SARS-CoV-2 variants of concern
An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies
Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models
Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants